AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 287: R592-R599, 2004. First published April 8, 2004; doi:10.1152/ajpregu.00412.2003
0363-6119/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/R592    most recent
00412.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barsness, K. A.
Right arrow Articles by McIntyre, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barsness, K. A.
Right arrow Articles by McIntyre, R. C.

INFLAMMATION AND CYTOKINES

Hemorrhage-induced acute lung injury is TLR-4 dependent

Katherine A. Barsness,1 John Arcaroli,2 Alden H. Harken,1 Edward Abraham,2 Anirban Banerjee,1 Leonid Reznikov,3 and Robert C. McIntyre1

1Department of Surgery, 2Division of Pulmonary and Critical Care Medicine, and 3Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, Colorado 80262

Submitted 23 July 2003 ; accepted in final form 1 April 2004


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Toll-like receptor 4 (TLR-4), initially identified as an LPS receptor, is critical to the signaling of a variety of danger signals, including heat shock protein 60, fibrinogen, and fibronectin. Recent data also suggest that TLR-4 plays a role in determining survival in both endotoxemia and hemorrhagic shock. We hypothesized that a functional TLR-4 would be required for hemorrhage and endotoxin-induced acute lung injury. Hemorrhage- and endotoxin-induced lung TNF-{alpha} mRNA and protein production, neutrophil accumulation, and protein permeability were dependent on a functional TLR-4. Hemorrhage-induced nuclear factor (NF)-{kappa}B activation was independent of functional TLR-4, whereas endotoxin-induced activation of NF-{kappa}B requires a functional TLR-4 for full response. Therefore, we conclude that 1) hemorrhage-induced acute lung injury is TLR-4 dependent and 2) hemorrhage has a different and distinct TLR-4-dependent intracellular activation mechanism compared with endotoxemia.

endotoxin; nuclear factor-{kappa}B; tumor necrosis factor-{alpha}

PREDISPOSING FACTORS for acute lung injury include hemorrhagic shock, sepsis, pancreatitis, and transfusion (23, 50). Activation of resident macrophages leads to increased expression of inflammatory cytokines and chemokines that recruit neutrophils to the lung (9, 10, 49). Neutrophils play a critical role in both hemorrhage- and endotoxin-induced acute lung injury (2, 45). However, there may be important pathophysiological differences in lung injury associated with different risk factors. The mechanisms leading to experimental acute inflammatory lung injury after hemorrhage differ from those associated with endotoxemia. Intracellular signaling pathways initiated by hemorrhage lead to increased expression of proinflammatory cytokines in lung neutrophils that are distinct from those associated with endotoxemia. In particular, xanthine oxidase-derived reactive oxygen intermediates appear to be involved in hemorrhage-induced signaling pathways but not in those initiated by endotoxemia (1, 37, 39).

The nuclear factor (NF)-{kappa}B family of transcription factors regulates gene induction of a variety of cytokines, chemokines, and adhesion molecules that ultimately lead to acute lung injury. NF-{kappa}B activation is an early event after both endotoxemia and hemorrhage (38, 42) and can be found in alveolar macrophages from patients with acute respiratory distress syndrome (26, 36). Inhibition of NF-{kappa}B abrogates neutrophil-mediated lung injury after endotoxin and lung ischemia-reperfusion (28, 35).

TLR-4 is the dominant mammalian signaling receptor for bacterial LPS (24, 33, 34). Whereas TLR-4 is widely recognized as the LPS receptor, other ligands of TLR-4 were recently identified, including heat shock protein (HSP) 60, fibrinogen, fibronectin, soluble heparin sulfate, and elastase (19, 30, 31, 46). The mechanisms by which a receptor classically described as the LPS receptor recognizes ligands with widely divergent protein sequences and structures remains to be elucidated. However, TLR-4 does appear to be a more promiscuous receptor for detecting widely divergent stimuli. These newly discovered ligands for TLR-4 comprise a growing list of endogenous ligands that may initiate a systemic inflammatory response in the absence of infection (18, 19). Despite these data on endogenous ligands, no study has yet determined a role for TLR-4 in a noninfectious, systemic, proinflammatory insult such as pancreatitis or hemorrhagic shock.

Significant insight into TLR-4 has come from a spontaneously occurring endotoxin hyporesponsive strain of mice. These endotoxin-resistant mice (C3H/HeJ) have a mutation in the LPS gene causing a critical amino acid substitution (proline 741 to histidine) in the cytoplasmic tail of TLR-4 commonly referred to as TLR-4d/d (34). In addition to being hyporesponsive to endotoxin, the C3H/HeJ strain exhibits an unexpected survival advantage in hemorrhagic shock (12). Specifically, there was a 65% reduction in hemorrhage-induced mortality in the C3H/HeJ strain compared with the wild type (WT). This C3H/HeJ survival advantage after hemorrhage was also accompanied by an inability to detect systemic TNF-{alpha}.

Given these observations that several endogenous ligands released in stress states can activate TLR-4 and that the TLR-4d/d mutation confers a survival advantage in hemorrhage, we hypothesized that inflammatory lung injury after hemorrhagic shock and endotoxemia would require a functional TLR-4. The purposes of this study were to determine the role of a functional TLR-4 after hemorrhagic shock or endotoxin on 1) NF-{kappa}B activation, 2) TNF-{alpha} mRNA and protein production, 3) neutrophil accumulation, and 4) protein permeability in the lung. We found that both hemorrhage- and endotoxin-induced acute lung injury were TLR-4 dependent. In addition, hemorrhage has a distinct and different TLR-4-dependent intracellular activation mechanism compared with endotoxemia.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals. Male C3H/HeN mice, 8–14 wk of age, were obtained from Charles River Laboratory. Male C3H/HeJ mice, 8–14 wk of age, were obtained from Jackson Laboratory. The mice were kept on a 12:12-h light/dark cycle with free access to food and water. All experiments were performed in accordance with institutional review board-approved protocols.

Materials. LPS (Escherichia coli serotype 055:B5) came from Sigma (St. Louis, MO). The Coomassie-Plus protein assay reagent was obtained from Pierce (Rockford, IL). A recombinant murine TNF-{alpha} ELISA kit was purchased from R&D Systems (Minneapolis, MN). A TransAM NF-{kappa}B p65/p50 Transcription Factor Assay kit was obtained from Active Motif (Carlsbad, CA).

Hemorrhage and endotoxin models. For the hemorrhage model, 30% of the calculated blood volume (~0.55 ml in a 20-g mouse) was withdrawn over 60 s from ketamine-xylazine-anesthetized mice by subzyphoid cardiac puncture. The mortality rate with this hemorrhage protocol was 14%, with all deaths occurring within the first several minutes of hemorrhage. This technique decreases mean arterial blood pressure to ~40 mmHg, with restoration to control levels over the 60 min after hemorrhage (37). Endotoxin was administered as an intraperitoneal injection of 1 mg/kg of E. coli LPS. These specific injury models were chosen because we previously found that a 30% hemorrhage compared with a dose of 1 mg/kg of intraperitoneal E. coli will produce the same degree of lung damage as assessed by wet-to-dry ratios (2).

Preparation of nuclear extracts. Isolation of nuclear extracts was performed as previously described (41). Briefly, lung samples were snap frozen in liquid nitrogen and stored at –70°C until time of assay. Lung tissue was homogenized with 300 µl of buffer A for 30 s. The homogenate was centrifuged at 2,750 rpm for 6 min at 4°C. The supernatant (cytoplasmic content) was discarded. The pellet was resuspended in 50 µl of buffer C and placed on ice for 15 min. The sample was centrifuged at 14,000 rpm for 10 min at 4°C. The supernatant was collected and stored in aliquots at –70°C. Protein concentration of the nuclear extract was determined using Coomassie Plus protein reagent standardized to bovine serum albumin according to manufacturer's protocol.

Electrophoretic mobility shift assay and NF-{kappa}B ELISA. Activation of the transcriptional factor NF-{kappa}B was determined by electrophoretic mobility shift assay (EMSA) analysis, as previously described (41). The consensus sequence for the immunoglobulin-{kappa}B gene was used. Synthetic DNA sequences (with enhancer motifs underlined) were annealed, forming double-strand DNA probes with single-strand ends consisting of sequences of four thymidines, allowing the ends to be labeled by base pairing with {alpha}-[32P]dATP using Sequenase DNA polymerase: {kappa}B, 5'-TTTTCGAGCTCGGGACTTTCC-GAGC-3', and 3'-GCTCGAGCCCTGAAAGGCTCGTTTT-5'.

DNA binding reaction mixtures of 20 µl contained 10 µg of nuclear extract, 10 mM Tris-Cl, pH 7.5, 50 mM EDTA, 0.5 mM dithiothreitol, 1 mM MgCl2, 4% glycerol, 0.08 µg of poly(dI-dC)-poly(dI-dC), and 0.7 fmol of 32P-labeled double-stranded oligonucleotide. After samples were incubated at room temperature for 20 min, they were loaded onto a 4% polyacrylamide gel (acrylamide-bis-acrylamide, 80:1; 2.5% glycerol in Tris-borate-EDTA) at 10 vol/cm. Each gel was then dried and subjected to autoradiography.

Translocation of the p65 subunit to the nucleus was measured by a TransAM NF-{kappa}B p65 Transcription Factor Assay kit. Results were determined by the spectophotometric absorbance at 655 nm on a microplate reader and expressed as optical density (OD655) per sample.

Polymerase chain reaction for TNF-{alpha} mRNA. One hour after endotoxin or hemorrhage, the lung was harvested and homogenized in Tri-reagent. The RNA was sequentially isolated after chloroform extraction and isopropanol precipitation. To evaluate yield and the quality of RNA, an aliquot of the preparation was electrophoresed in agarose in the presence of ethidium bromide. The reasonable estimation of yield was made by running 10 µl of the RNA sample (~0.5–1.0 µg) in agarose with a known amount of dilute standard RNA solution prepared from concentrated RNA stock solution that has been quantified by UV absorbance. Samples were separated on a 1% gel containing 0.5x TBE (50 mM Tris, 45 mM boric acid, 0.5 mM EDTA pH 8.3) with 0.5 µg/ml ethidium bromide visualized by UV illumination and photographed.

To prepare cDNA, 1–3 µg of total RNA was reverse transcribed by using random primer in a final concentration of 5.5 mM MgCl2, 50 mM KCl, and 10 mM Tris·HCl (pH 8.3), 0.5 mM of each dNTPs, 20 U of RNase inhibitor, and 50 U of MultiScribe reverse transcriptase (Perkin Elmer). The reaction was incubated at room temperature for 10 min, 37°C for 60 min, and then terminated by a 95°C incubation for 5 min.

To ensure that the RNA isolated from lung tissue and the synthesized template for PCR were of sufficient quality for use in real-time RT-PCR, the amplification with primers and probes designed for 18S and {beta}-actin were performed for each sample using ABI Prism 7700. Samples that failed to reach the threshold within 14 cycles for 18S or 21 cycles for {beta}-actin were excluded from the study as they did not pass the quality control.

TaqMan real-time quantitative PCR was performed by amplifying mixtures containing 100 nmol of selected probes, 200 nM of primers, and target cDNA template at 94°C for 20 s and 62°C for 1 min for 50 cycles using ABI PRISM 7700 sequence detector (Applied Biosystems) according to the manufacturer's protocol. During each PCR cycle, the 5' to 3' exonuclease activity of DNA polymerase cleaves the TaqMan probe, thereby increasing the fluorescence of the reporter dye at the appropriate wavelength. The increase in fluorescence is proportional to the concentration of template in the PCR. The threshold was calculated according manufacturer's protocol for the TaqMan PCR kit. The number of PCR cycles required for a particular gene amplification to reach this threshold is represented as "CT." To normalize this value using an internal standard, the CT value representing 18S amplification is subtracted from CT corresponding to amplification of target gene. The result is represented as {Delta}CT.

To calculate the relative gene expression, {Delta}CT corresponding to a target gene was subtracted from {Delta}CT of the gene selected as a calibrator (18S ribosomal RNA). The result was represented as {Delta}{Delta}CT. The relative number of amplified target oligonucleotide copies was then calculated as 2({Delta}{Delta}CT). Results are expressed as nanograms TNF-{alpha} mRNA per nanogram ribosomal RNA.

TNF-{alpha} ELISA. Lung tissue was homogenized with 4 vol of homogenate buffer and centrifuged at 10,000 rpm for 20 min at 4°C. The supernatant was collected for ELISA determination of TNF-{alpha} as previously described. The detection limit was 5.1 pg/ml for TNF-{alpha}. Absorbance of standards and samples was determined spectrophotometrically at 450 nm using a microplate reader (Bio-Rad, Hercules, CA). Results were plotted against the linear portion of the standard curve. TNF-{alpha} levels are expressed as picograms per gram of protein as determined using Coomassie Plus protein assay.

Myeloperoxidase assay. Four hours after a 30% hemorrhage, neutrophils accumulate in the parenchyma (interstitium) of the lung. Interestingly, neutrophil accumulation after systemic LPS reveals a predominantly intravascular adherence pattern of neutrophils (48). This adherence is firm and therefore not capable of being flushed from the lungs before fixation or imaging or processing for myeloperoxidase (MPO) assays. Despite the intravascular location, the neutrophil has an important role in endotoxin-mediated tissue injury. This role is revealed by neutrophil depletion, which prevents the development of lung edema (2, 44). The method for MPO assay has been described previously with minor modifications (45). Tissue was homogenized for 30 s in 10x volume 20 mM potassium phosphate buffer (pH 7.4). The homogenate was centrifuged at 24,000 rpm for 30 min at 4°C. The pellet was resuspended and sonicated on ice for 90 s in 2x volume hexadecyltrimethylammonium bromide buffer (HTAB: 0.5% hexadecyltrimethylammonium bromide in 50 mM potassium phosphate, pH 6.0). Samples were incubated in water bath (56–60°C) for 2 h and then centrifuged at 5,000 g for 10 min. The supernatant was collected for assay of MPO activity as determined by measuring the H2O2-dependent oxidation of 3,3',5,5'-tetramethylbenzidine at 460 nm. All assay measurements were corrected for total grams protein in each sample, as determined by Coomassie Plus protein reagent and expressed as optical density (OD450) per sample.

Evaluation of lung protein permeability. We evaluated lung permeability using the previously published method of Evans blue dye extravasation (32). Evans blue dye binds tightly to albumin and is a sensitive marker of vascular permeability. Evans blue dye was injected into the mice via femoral vein (cut down performed under anesthesia) 3 h after endotoxin or cardiac puncture. The vein was ligated after injection and the skin was closed. One hour after the injection of Evans blue dye, the lung tissue was flushed in situ through the right ventricle with 10 ml normal saline to clear intravascular dye. The lung tissue was homogenized in formamide (1:5 dilution) and then allowed to incubate at 37°C for 18 h. The homogenate was centrifuged, and the resultant supernatant was evaluated for spectrophotometric absorbance at 655 nm on a microplate reader. Results are expressed as optical density (OD655) per sample.

Statistical analysis. Data are expressed as means ± SE. An ANOVA was performed with Statview 4.0 statistical analysis software (SAS Institute, Cary, NC), and a difference was accepted as significant if the P value was equal to, or smaller than, 0.05 as verified by the Bonferroni-Dunn post hoc test.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
NF-{kappa}B in TLR-4d/d after hemorrhage and endotoxemia. NF-{kappa}B activation is a proximal step in hemorrhage- and endotoxin-induced lung injury (38, 42). To determine if hemorrhage- or endotoxin-induced NF-{kappa}B activation required a functional TLR-4, we used a p65 ELISA to examine the amount of the p65 subunit of NF-{kappa}B in the nuclear fraction of lung tissue in WT and TLR-4d/d mice 1 h after injury. As depicted in Fig. 1, hemorrhage-induced NF-{kappa}B translocation is equivalent in WT and TLR-4d/d. Endotoxin induced a dramatic increase in NF-{kappa}B translocation in WT (P < 0.01 vs. control). This effect was attenuated in TLR-4d/d (P < 0.01 vs. WT). We also measured NF-{kappa}B-DNA binding with EMSA (Fig. 2), and the results were concordant with the p65 ELISA.



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 1. Translocation of the p65 subunit of nuclear factor (NF)-{kappa}B to the nucleus as determined by p65 ELISA of the nuclear extract of whole lung 1 h after hemorrhage (HS) or endotoxemia (LPS). The increase in nuclear p65 was equivalent in wild type (WT) and toll-like receptor (TLR)-4d/d after hemorrhage [*P < 0.01 vs. controls (Ct)]. Endotoxin induced a dramatic increase in nuclear translocation of p65 in WT (*P < 0.01 vs. Ct). Endotoxin-induced nuclear translocation of p65 was attenuated in TLR-4d/d ({dagger}P < 0.01 vs. WT).

 


View larger version (32K):
[in this window]
[in a new window]
  		Fig. 2. NF-{kappa}B electrophoretic mobility shift assay of the nuclear extract of lung 1 h after hemorrhage (HS) or endotoxemia (LPS). (Exposure times for the hemorrhage and endotoxin-induced NF-{kappa}B activation were equivalent at 1 h.) There is equivalent NF-{kappa}B activation in WT and TLR-4d/d after hemorrhage. Endotoxin induced a dramatic increase in NF-{kappa}B activation in WT that was attenuated in TLR-4d/d.

 
TNF-{alpha} production in TLR-4d/d after hemorrhage and endotoxemia. We previously showed that TNF-{alpha} is required for hemorrhage- and endotoxin-induced lung injury (3, 10, 47). Therefore, we evaluated hemorrhage- and endotoxin-induced TNF-{alpha} mRNA and protein production in WT and TLR-4d/d lung tissue 1 h after injury. As shown in Fig. 3A, hemorrhage induced an increase in TNF-{alpha} mRNA in WT that was not seen in TLR-4d/d (P < 0.05 vs. control and TLR-4d/d). Endotoxin (Fig. 3B) induced an increase in TNF-{alpha} mRNA in WT and TLR-4d/d; however, there was a 10-fold greater increase in WT compared with TLR-4d/d (P < 0.05 vs. TLR-4d/d). TNF-{alpha} protein production roughly paralleled mRNA production with increased TNF-{alpha} in hemorrhaged WT lung tissue but not in hemorrhaged TLR-4d/d (Fig. 3C). In endotoxin-treated mice, WT had a dramatic increase in TNF-{alpha} production that was significantly reduced in TLR-4d/d (Fig. 3D).



View larger version (27K):
[in this window]
[in a new window]
  		Fig. 3. TNF-{alpha} mRNA (by RT-PCR) and protein production (by ELISA) 1 h after hemorrhage (HS) or endotoxemia (LPS). Hemorrhage induced an increase in TNF-{alpha} mRNA (A) and protein (C) in WT (*P < 0.01 vs. Ct) but not in TLR-4d/d. Endotoxin induced TNF-{alpha} mRNA (B) and protein (D) in WT (*P < 0.01 vs. Ct). There was decreased endotoxin-induced TNF-{alpha} mRNA and protein in TLR-4d/d ({dagger}P < 0.01 vs. WT).

 
Lung neutrophil accumulation in TLR-4d/d after hemorrhage and endotoxemia. We evaluated neutrophil accumulation in WT and TLR-4d/d lung tissue by MPO assay 4 h after injury (Fig. 4). Hemorrhage increased lung neutrophil recruitment in WT (P < 0.05 vs. control). There was no increase in neutrophil recruitment in TLR-4d/d (P < 0.05 vs. WT). Similarly, endotoxin increased neutrophil recruitment in WT (P < 0.05 vs. control) but not TLR-4d/d (P < 0.05 vs. WT).



View larger version (21K):
[in this window]
[in a new window]
  		Fig. 4. Lung neutrophil accumulation as assessed by myeloperoxidase (MPO) activity 4 h after hemorrhage (HS) or endotoxemia (LPS). Hemorrhage and endotoxin increased neutrophil accumulation in WT (*P < 0.01 vs. Ct). There was no increase in lung neutrophil accumulation after hemorrhage or endotoxin in TLR-4d/d ({dagger}P < 0.01 vs. WT).

 
Lung permeability in TLR-4d/d after hemorrhage and endotoxemia. We previously determined that 30% hemorrhage or 1 mg/kg of intraperitoneal endotoxin induces equivalent degrees of acute lung edema in mice as assessed by an increased lung wet-to-dry weight ratio (4, 39, 42). To assess whether end organ damage was abrogated in TLR-4d/d, we evaluated lung protein permeability by measurement of extravasation of Evans blue dye 4 h after hemorrhage or endotoxin. As depicted in Fig. 5, both hemorrhage and endotoxemia caused an increase in lung leak in WT 4 h after injury (P < 0.05 vs. controls). However, neither hemorrhage nor endotoxemia caused an increase in lung leak in TLR-4d/d (P = 0.72 vs. control).



View larger version (20K):
[in this window]
[in a new window]
  		Fig. 5. Acute lung leak as assessed by extravasation of Evans blue dye (EBD) 4 h after hemorrhage (HS) or endotoxemia (LPS). Hemorrhage and endotoxemia induced an increase in lung leak in WT (*P < 0.01 vs. Ct.). There was no increase in lung leak after hemorrhage or endotoxin in TLR-4d/d ({dagger}P < 0.01 vs. WT).

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
TLR-4 has an intracellular toll-IL-1 receptor (TIR) domain that recruits the adapter protein MyD88 (8, 25, 51). The TLR-4 bound MyD88 then recruits a signaling kinase, IL-1 receptor associated kinase (IRAK), for subsequent downstream signaling cascades (27, 51). The C3H/HeJ (TLR-4d/d) strain used in this experiment has a naturally occurring TLR-4 mutation with the defect in the intracellular TIR domain (33, 34). The principal function of the TIR domain is to mediate homotypic protein-protein interactions in the signal transduction process. The defective TLR-4 is thus unable to recruit MyD88 with resultant interruption of the dominant signaling cascade for the TLR-4 receptor (52). Despite the inability of the TLR-4d/d to recruit MyD88, this strain still exhibits hemorrhage- and endotoxin-induced NF-{kappa}B activation (13). However, only in the WT strain was NF-{kappa}B activation able to induce TNF-{alpha} protein production. Another study documented LPS-induced TNF-{alpha} protein production both systemically and in lung tissue, albeit with different kinetics than that found in the WT mice (29). These findings all suggest that MyD88-independent pathways leading to NF-{kappa}B activation are intact in the TLR-4d/d, yet a functional TLR-4 is required for full LPS-induced activation of the NF-{kappa}B transcriptional complex and resultant TNF-{alpha} production. Our data are consistent with these previous findings. NF-{kappa}B was similar between the TLR-4d/d and WT after hemorrhage. Although it was decreased compared with WT, there was still NF-{kappa}B activation in the TLR-4d/d after endotoxin compared with baseline. Thus MyD88-independent pathways may still activate NF-{kappa}B in the TLR-4d/d strain. However, the TLR-4-MyD88 pathway is required for a full expression of TNF-{alpha}.

The role of MyD88-independent signaling is further highlighted in recent studies in MyD88 knockout mice. Kawai et al. (21) found that endotoxin-induced NF-{kappa}B and mitogen activated protein kinase (MAPK) activation in MyD88-deficient mice, albeit with different kinetics from WT mice. Despite delayed activation of NF-{kappa}B and MAPK, MyD88 knockout mice did not produce TNF-{alpha} mRNA or protein. Recent evidence suggests that at least some of the MyD88-independent signaling occurs through two alternate adapter molecules, TIR domain-containing adapter protein (TIRAP) and TIR domain-containing adapter inducing IFN-{beta} (TRIF) (17, 53). Interestingly, TIRAP knockout mice also exhibit delayed activation of NF-{kappa}B in response to endotoxin (17). Therefore, whereas MyD88 is the dominant TLR-4 signaling pathway and is required for downstream cytokine production, there are MyD88-independent pathways that can continue to activate transcription factors in TLR-4d/d.

We also evaluated endotoxin- and hemorrhage-induced TNF-{alpha} message and protein levels in WT and TLR-4. Similar to what others found (20), the relative reduction of endotoxin-induced NF-{kappa}B activation in TLR-4d/d correlated with the reduction in TNF-{alpha} mRNA and protein production. Despite equivalent hemorrhage-induced activation of NF-{kappa}B in WT and TLR-4d/d, there was no increase in TNF-{alpha} mRNA or protein production in TLR-4d/d. This finding suggests that there is hemorrhage-induced TLR-4-dependent regulation of the intranuclear NF-{kappa}B transcriptional complex. Regulation of the transcriptional activity of NF-{kappa}B is a complex combination of direct protein modifications and intranuclear protein-protein interactions, all of which work in concert to create an active transcriptional complex. An early protein modification of NF-{kappa}B is phosphorylation of the p65 subunit by protein kinase A, Casein kinase II, or I {kappa}B kinase. Beyond direct p65 modification, there are numerous coactivators that are required for initiation or potentiation of the transcriptional complex, including CBP and p300 (43). Finally, NF-{kappa}B transcriptional regulation occurs at the level of histone acetylation. Therefore, the regulation of NF-{kappa}B transcriptional activation is an extremely complex area with numerous levels of regulation that may individually or in summation affect the transcriptional activity of NF-{kappa}B after both hemorrhage and endotoxemia. Any one of these mechanisms may contribute to the observed decrease in TNF expression despite NF-{kappa}B activation in the TLR-4d/d strain.

The final common effect of both hemorrhage- and endotoxin-induced cytokine and chemokine production is the recruitment of neutrophils into organ systems resulting in tissue injury (Fig. 6). In our study, neither hemorrhage nor endotoxemia caused lung neutrophil recruitment or acute lung injury in TLR-4d/d. TNF-{alpha} is believed to be one of many cytokines involved in the evolution of lung injury after hemorrhage and endotoxin (3, 10, 47). We previously showed that even a very low level of lung TNF-{alpha} is critical to the development of acute lung injury after hemorrhagic shock (47). Similarly, TNF-{alpha} is also involved in endotoxin-induced lung injury as demonstrated by the lack of injury in TNF receptor-1 knockout mice (10). Furthermore, TNF-binding protein prevents endotoxin-induced acute lung injury (44). Although the absolute levels of TNF-{alpha} were proportionately different after hemorrhage and endotoxin, WT lung injury as assessed using Evans blue dye extravasation was equivalent in magnitude in these two injuries. These data on the extent of hemorrhage- or endotoxin-induced lung injury were consistent with our previous findings that 30% hemorrhage compared with 1 mg/kg of intraperitoneal endotoxin results in widely divergent TNF-{alpha} production, yet similar lung neutrophil recruitment and wet-to-dry ratios (2). We chose to evaluate lung TNF-{alpha} on the basis of its important role in lung injury after both endotoxin and hemorrhage, as detailed above (3, 10, 47). Furthermore, DeMaria et al. (12) found that serum TNF was decreased after hemorrhage in TLR-4d/d compared with WT. However, TNF-{alpha} is just one of many potential factors that have been implicated in lung neutrophil recruitment and the development of acute lung injury. Therefore, the protection against neutrophil recruitment and lung injury seen in TLR-4d/d after hemorrhage and endotoxin is unlikely to be explained only by reduction in TNF-{alpha} production.



View larger version (16K):
[in this window]
[in a new window]
  		Fig. 6. Schematic of hemorrhage (HS) and endotoxin (LPS)-induced intracellular pathways leading to acute lung injury. Endpoints for the study are in the boxes to the right. EMSA, electromobility shift assay; MPO, myeloperoxidase assay. TIRAP, toll-IL-1 receptor (TIR) domain-containing adapter protein; TRIF, TIR domain-containing adapter inducing IFN-{beta}.

 
Bacterial translocation may be a confounding factor in hemorrhagic shock. Translocation of gut-derived bacteria across the intestinal barrier was previously demonstrated in a variety of hemorrhagic shock models. Deitch et al. (11) reported a 61% incidence of bacterial translocation in rats 24 h after hemorrhage and resuscitation. Similarly, Baker et al. (7) demonstrated enteric bacteria in a variety of organs 24 h after rats had been subjected to varying degrees of shock. However, this phenomenon has not been conclusively shown to play a role in the expression of cytokines or tissue injury in hemorrhaged mice. Ayala et al. (6) determined that hemorrhage-induced serum TNF-{alpha} levels were not associated with systemic endotoxemia in mice. Similarly, Grotz et al. (16) did not find any endotoxin in portal or systemic blood after hemorrhage in the rat. We previously demonstrated that our nonresuscitated, 30% hemorrhage model does not induce endotoxemia (as determined by limulus assay) (3, 37, 40). Our data demonstrate a divergence between hemorrhage- and endotoxin-induced NF-{kappa}B activation and TNF-{alpha} production. If the findings were due strictly to endotoxemia (bacterial translocation) after hemorrhage, we would have expected similar activation patterns throughout all of the experiments. Thus these current data suggest that translocation and endotoxemia do not contribute to the pathophysiology of hemorrhage-induced lung injury in keeping with both our own and Ayala et al.'s (6) previous observations.

Other investigators evaluated TLR-4 expression and function in a variety of injury models. DeMaria and colleagues (12) performed an approximate 45% hemorrhage on C3H/HeJ (TLR-4d/d) mice and determined that they had increased survival and decreased systemic TNF-{alpha} compared with hemorrhaged controls. In a two-hit model of hemorrhage followed by intratracheal endotoxin, TLR-4 expression was controlled both transcriptionally and posttranscriptionally via altered mRNA stability (14). Furthermore, the first hit of shock/resuscitation appeared to regulate TLR-4 gene expression. Finally, Ayala and colleagues (5) evaluated the role of TLR-4 in a two-hit model of hemorrhage followed by cecal ligation and puncture (CLP). In this study, hemorrhage-induced neutrophil priming for subsequent CLP-induced lung injury required a functional TLR-4. These results closely parallel our own that hemorrhagic shock induces subsequent inflammatory responses through TLR-4 signaling mechanisms.

The innate immune system can identify and initiate a response to a wide variety of invading microorganisms through the various toll-like receptors. However, TLR-4 is unique in its ability to recognize both exogenous (foreign or non-self) and endogenous (self) proteins. The endogenous TLR-4 ligands, including heat shock proteins (60 and 70), the extra domain A of fibronectin, oligosaccharides of hyaluronic acid, polysaccharide fragments of heparan sulfate, elastase, and fibrinogen, are all proteins that are either released or produced by cells undergoing stress or abnormal cell death. Therefore, TLR-4's role in innate immunity extends far beyond its initial description as a pattern recognition receptor for exogenous bacterial products. Rather, TLR-4 is emerging as a more comprehensive receptor for danger signals. Whether the initiating ligand originates from gram-negative bacteria, the abnormal release of intracellular proteins, the production of extracellular matrix proteins or the more global stress of hemorrhagic shock, a functional TLR-4 is required for subsequent inflammatory signaling. A more descriptive classification of TLR-4 as a danger signal receptor would be consistent with the "danger model" of innate immunity as proposed by Matzinger (22). In the danger model, the innate immune system is less concerned with identifying non-self antigens and more concerned with sensing danger from the surrounding tissues. As such, the endogenous danger ligands are those products released from cells in response to stress or undergoing abnormal death. These danger ligands then initiate a host immune response. The danger model thereby allows for, or explains, the activation of the innate immune system by factors other than foreign antigens. Our data on hemorrhagic shock support the danger model and the hypothesis that TLR-4 is more of a danger signal receptor than just merely a pattern recognition receptor. This emerging role for TLR-4 as a danger signal receptor may or may not extend to other toll-like receptors. Currently, only TLR-2 has been demonstrated to signal for an endogenous protein (HSP70) and this is not entirely certain, as recent investigations have revealed bacterial contamination as a potential confounder in HSP70 signaling (15). Interestingly, whereas contemporary literature supports the role of TLR-4 in deleterious danger signaling, these data do not necessarily exclude a beneficial role for TLR-4 signaling in as yet to be determined signaling pathways.

In summary, we determined that hemorrhage and endotoxin induce NF-{kappa}B activation, TNF-{alpha} mRNA and protein production, lung neutrophil accumulation, and acute lung injury. Furthermore, all of these findings are attenuated in endotoxin-treated TLR-4d/d mice. Interestingly, hemorrhaged TLR-4d/d mice have attenuated TNF-{alpha} mRNA and protein, lung neutrophil accumulation, and acute lung injury but no attenuation in NF-{kappa}B activation. Therefore, we conclude that 1) TLR-4 is an important receptor in hemorrhage-induced acute lung injury and 2) hemorrhage-induced TLR-4 signaling occurs by a distinct and different activation pattern than endotoxemia.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This research was supported by National Institutes of Health (NIH) Trauma Center Grant P50-GM-49222–10 and NIH Training Grant T32-GM-08315–12.


   FOOTNOTES
 

Address for reprint requests and other correspondence: K. A. Barsness, 4200 E. Ninth Ave., Box C320, Denver, CO 80262 (E-mail: katherine.barsness{at}uchsc.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Abraham E, Arcaroli J, and Shenkar R. Activation of extracellular signal-regulated kinases, NF-kappa B, and cyclic adenosine 5'-monophosphate response element-binding protein in lung neutrophils occurs by differing mechanisms after hemorrhage or endotoxemia. J Immunol 166: 522–530, 2001.[Abstract/Free Full Text]
  2. Abraham E, Carmody A, Shenkar R, and Arcaroli J. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 279: L1137–L1145, 2000.[Abstract/Free Full Text]
  3. Abraham E, Jesmok G, Tuder R, Allbee J, and Chang YH. Contribution of tumor necrosis factor-alpha to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. Crit Care Med 23: 1319–1326, 1995.[CrossRef][ISI][Medline]
  4. Arcaroli J, Yang KY, Yum HK, Kupfner J, Pitts TM, Park JS, Strassheim D, and Abraham E. Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J Leukoc Biol 72: 571–579, 2002.[Abstract/Free Full Text]
  5. Ayala A, Chung CS, Lomas JL, Song GY, Doughty LA, Gregory SH, Cioffi WG, LeBlanc BW, Reichner J, Simms HH, and Grutkoski PS. Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol 161: 2283–2294, 2002.[Abstract/Free Full Text]
  6. Ayala A, Perrin MM, Meldrum DR, Ertel W, and Chaudry IH. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2: 170–174, 1990.[CrossRef][Medline]
  7. Baker JW, Deitch EA, Li M, Berg RD, and Specian RD. Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 28: 896–906, 1988.[ISI][Medline]
  8. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Di Marco F, French L, and Tschopp J. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273: 12203–12209, 1998.[Abstract/Free Full Text]
  9. Calkins CM, Barsness K, Bensard DD, Vasquez-Torres A, Raeburn CD, Meng X, and McIntyre RC Jr. Toll-like receptor-4 signaling mediates pulmonary neutrophil sequestration in response to gram-positive bacterial enterotoxin. J Surg Res 104: 124–130, 2002.[CrossRef][ISI][Medline]
  10. Calkins CM, Heimbach JK, Bensard DD, Song Y, Raeburn CD, Meng X, and McIntyre RC Jr. TNF receptor I mediates chemokine production and neutrophil accumulation in the lung following systemic lipopolysaccharide. J Surg Res 101: 232–237, 2001.[CrossRef][ISI][Medline]
  11. Deitch EA, Bridges W, Baker J, Ma JW, Ma L, Grisham MB, Granger DN, Specian RD, and Berg R. Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery 104: 191–198, 1988.[ISI][Medline]
  12. DeMaria EJ, Pellicane JV, and Lee RB. Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor. J Trauma 35: 720–725, 1993.[ISI][Medline]
  13. Ding A, Hwang S, Lander HM, and Xie QW. Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-kappa B. J Leukoc Biol 57: 174–179, 1995.[Abstract]
  14. Fan J, Kapus A, Marsden PA, Li YH, Oreopoulos G, Marshall JC, Frantz S, Kelly RA, Medzhitov R, and Rotstein OD. Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J Immunol 168: 5252–5259, 2002.[Abstract/Free Full Text]
  15. Gao B and Tsan MF. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem 278: 174–179, 2003.[Abstract/Free Full Text]
  16. Grotz MR, Ding J, Guo W, Huang Q, and Deitch EA. Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock 3: 362–368, 1995.[ISI][Medline]
  17. Horng T, Barton GM, Flavell RA, and Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420: 329–333, 2002.[CrossRef][Medline]
  18. Johnson GB, Brunn GJ, and Platt JL. Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol 23: 15–44, 2003.[CrossRef][ISI][Medline]
  19. Johnson GB, Brunn GJ, and Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol 172: 20–24, 2004.[Abstract/Free Full Text]
  20. Jongeneel CV. Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology 193: 210–216, 1995.[ISI][Medline]
  21. Kawai T, Adachi O, Ogawa T, Takeda K, and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115–122, 1999.[CrossRef][ISI][Medline]
  22. Matzinger P. The danger model: a renewed sense of self. Science 296: 301–305, 2002.[Abstract/Free Full Text]
  23. McIntyre RC Jr, Pulido EJ, Bensard DD, Shames BD, and Abraham E. Thirty years of clinical trials in acute respiratory distress syndrome. Crit Care Med 28: 3314–3331, 2000.[CrossRef][ISI][Medline]
  24. Medzhitov R, Preston-Hurlburt P, and Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394–397, 1997.[CrossRef][Medline]
  25. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, and Janeway CA Jr. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2: 253–258, 1998.[CrossRef][ISI][Medline]
  26. Moine P, McIntyre R, Schwartz MD, Kaneko D, Shenkar R, Le Tulzo Y, Moore EE, and Abraham E. NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13: 85–91, 2000.[ISI][Medline]
  27. Muzio M, Ni J, Feng P, and Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278: 1612–1615, 1997.[Abstract/Free Full Text]
  28. Nathens AB, Bitar R, Davreux C, Bujard M, Marshall JC, Dackiw AP, Watson RW, and Rotstein OD. Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol 17: 608–616, 1997.[Abstract/Free Full Text]
  29. Nill MR, Oberyszyn TM, Ross MS, Oberyszyn AS, and Robertson FM. Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice. J Leukoc Biol 58: 563–574, 1995.[Abstract]
  30. Ohashi K, Burkart V, Flohe S, and Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164: 558–561, 2000.[Abstract/Free Full Text]
  31. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, and Strauss JF 3rd. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276: 10229–10233, 2001.[Abstract/Free Full Text]
  32. Patterson CE, Rhoades RA, and Garcia JG. Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol 72: 865–873, 1992.[Abstract/Free Full Text]
  33. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085–2088, 1998.[Abstract/Free Full Text]
  34. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, and Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189: 615–625, 1999.[Abstract/Free Full Text]
  35. Ross SD, Kron IL, Gangemi JJ, Shockey KS, Stoler M, Kern JA, Tribble CG, and Laubach VE. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-kappaB. Am J Physiol Lung Cell Mol Physiol 279: L528–L536, 2000.[Abstract/Free Full Text]
  36. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, and Abraham E. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 24: 1285–1292, 1996.[CrossRef][ISI][Medline]
  37. Schwartz MD, Repine JE, and Abraham E. Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am J Respir Cell Mol Biol 12: 434–440, 1995.[Abstract]
  38. Shenkar R and Abraham E. Hemorrhage induces rapid in vivo activation of CREB and NF-kappaB in murine intraparenchymal lung mononuclear cells. Am J Respir Cell Mol Biol 16: 145–152, 1997.[Abstract]
  39. Shenkar R and Abraham E. Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 163: 954–962, 1999.[Abstract/Free Full Text]
  40. Shenkar R, Coulson WF, and Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol 10: 290–297, 1994.[Abstract]
  41. Shenkar R, Schwartz MD, Terada LS, Repine JE, McCord J, and Abraham E. Hemorrhage activates NF-kappa B in murine lung mononuclear cells in vivo. Am J Physiol Lung Cell Mol Physiol 270: L729–L735, 1996.[Abstract/Free Full Text]
  42. Shenkar R, Yum HK, Arcaroli J, Kupfner J, and Abraham E. Interactions between CBP, NF-{kappa}B, and CREB in the lungs after hemorrhage and endotoxemia. Am J Physiol Lung Cell Mol Physiol 281: L418–L426, 2001.[Abstract/Free Full Text]
  43. Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, and Collins T. Transcriptional activation by NF-{kappa}B requires multiple coactivators. Mol Cell Biol 19: 6367–6378, 1999.[Abstract/Free Full Text]
  44. Sheridan BC, Dinarello CA, Meldrum DR, Fullerton DA, Selzman CH, and McIntyre RC Jr. Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 277: L861–L867, 1999.[Abstract/Free Full Text]
  45. Sheridan BC, McIntyre RC, Agrafojo J, Meldrum DR, Meng X, and Fullerton DA. Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation. Am J Physiol Lung Cell Mol Physiol 271: L820–L828, 1996.[Abstract/Free Full Text]
  46. Smiley ST, King JA, and Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167: 2887–2894, 2001.[Abstract/Free Full Text]
  47. Song Y, Ao L, Raeburn CD, Calkins CM, Abraham E, Harken AH, and Meng X. A low level of TNF-{alpha} mediates hemorrhage-induced acute lung injury via p55 TNF receptor. Am J Physiol Lung Cell Mol Physiol 281: L677–L684, 2001.[Abstract/Free Full Text]
  48. Tsuji C, Minhaz MU, Shioya S, Fukahori M, Tanigaki T, and Nakazawa H. The importance of polymorphonuclear leukocytes in lipopolysaccharide-induced superoxide anion production and lung injury: ex vivo observation in rat lungs. Lung 176: 1–13, 1998.[CrossRef][ISI][Medline]
  49. Ulich TR, Howard SC, Remick DG, Wittwer A, Yi ES, Yin S, Guo K, Welply JK, and Williams JH. Intratracheal administration of endotoxin and cytokines. VI Antiserum to CINC inhibits acute inflammation. Am J Physiol Lung Cell Mol Physiol 268: L245–L250, 1995.[Abstract/Free Full Text]
  50. Ware LB and Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334–1349, 2000.[Free Full Text]
  51. Wesche H, Henzel WJ, Shillinglaw W, Li S, and Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7: 837–847, 1997.[CrossRef][ISI][Medline]
  52. Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley JL, and Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408: 111–115, 2000.[CrossRef][Medline]
  53. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, and Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 169: 6668–6672, 2002.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
E. Lorne, J. W. Zmijewski, X. Zhao, G. Liu, Y. Tsuruta, Y.-J. Park, H. Dupont, and E. Abraham
Role of extracellular superoxide in neutrophil activation: interactions between xanthine oxidase and TLR4 induce proinflammatory cytokine production
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C985 - C993.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
D. J. Kaczorowski, K. P. Mollen, R. Edmonds, and T. R. Billiar
Early events in the recognition of danger signals after tissue injury
J. Leukoc. Biol., March 1, 2008; 83(3): 546 - 552.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. P. Mollen, R. M. Levy, J. M. Prince, R. A. Hoffman, M. J. Scott, D. J. Kaczorowski, R. Vallabhaneni, Y. Vodovotz, and T. R. Billiar
Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells
J. Leukoc. Biol., January 1, 2008; 83(1): 80 - 88.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Tsung, J. R. Klune, X. Zhang, G. Jeyabalan, Z. Cao, X. Peng, D. B. Stolz, D. A. Geller, M. R. Rosengart, and T. R. Billiar
HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling
J. Exp. Med., November 26, 2007; 204(12): 2913 - 2923.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. M. Levy, K. P. Mollen, J. M. Prince, D. J. Kaczorowski, R. Vallabhaneni, S. Liu, K. J. Tracey, M. T. Lotze, D. J. Hackam, M. P. Fink, et al.
Systemic inflammation and remote organ injury following trauma require HMGB1
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1538 - R1544.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. Tsung, N. Zheng, G. Jeyabalan, K. Izuishi, J. R. Klune, D. A. Geller, M. T. Lotze, L. Lu, and T. R. Billiar
Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury
J. Leukoc. Biol., January 1, 2007; 81(1): 119 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. M. Levy, J. M. Prince, R. Yang, K. P. Mollen, H. Liao, G. A. Watson, M. P. Fink, Y. Vodovotz, and T. R. Billiar
Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R970 - R976.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Szalay, T. Shimizu, T. Suzuki, H.-P. Yu, M. A. Choudhry, M. G. Schwacha, L. W. Rue III, K. I. Bland, and I. H. Chaudry
Estradiol improves cardiac and hepatic function after trauma-hemorrhage: role of enhanced heat shock protein expression
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R812 - R818.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. R. Jacobson, J. W. Barnard, D. N. Grigoryev, S.-F. Ma, R. M. Tuder, and J. G. N. Garcia
Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1026 - L1032.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Y. Kim, J. S. Park, D. Strassheim, I. Douglas, F. Diaz del Valle, K. Asehnoune, S. Mitra, S. H. Kwak, S. Yamada, I. Maruyama, et al.
HMGB1 contributes to the development of acute lung injury after hemorrhage
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L958 - L965.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/R592    most recent
00412.2003v1
Right arrow